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Biomaterials that can drive stem cells to an appropriate differentiation level and decrease apoptosis of transplanted cells are
needed in regenerative medicine. Nanomaterials are promising novel materials for such applications. Here we reported that
carboxylated multiwalled carbon nanotube (MWCNT 1) promotes myogenic differentiation of mouse myoblast cells and inhibits
cellapoptosisunderthedifferentiationconditionsbyregulatingbasichelix-loop-helixtranscriptionfactors.MWCNT1attenuates
bone morphogenetic protein receptor (BMPR) signaling activity by binding to BMPR2 and attenuating the phosphorylation of
BMPR1. This molecular understanding allowed us to tune stem cell differentiation to various levels by chemical modiﬁcations,
demonstrating human control of biological activities of nanoparticles and opening an avenue for potential applications of
nanomaterials in regenerative medicine.
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Nanotechnology has evolved rapidly and has an impact on
nearly every aspect in modern society including medicine. For
example, carbon nanotube (CNT) materials have shown
promising potentials in drug
1 and gene delivery,
2 cancer cell
imaging
3 and regenerative medicine. CNT has been able to
direct the differentiation of mouse embryonal carcinoma stem
cells
4andpromoteneuralstemcelldifferentiationfromhuman
embryonic stem cells.
5
Adult stem cells, the undifferentiated cells residing in
mature organs or tissues, can renew themselves and
differentiate to cells of the specialized tissues or organs.
Because of the less controversial aspect of their use than
embryonic stem cells, the easy accessibility, and their
capability to divide in cell cultures, adult stem cells provide
valuable cell sources to treat and cure many regenerative
diseases. Induction of myogenic differentiation from different
adult stem cells is promising to cure diseases like muscular
dystrophies,
6 cardiac myocyte death
7 and muscle damage.
For example, mesenchymal stem cells identiﬁed from bone
marrow have been successfully used for repairing heart
muscle in cardiac ischemia.
7,8 However, this application is
limited by the poor viability of the transplanted cells caused by
the pathological milieu and loss of survival signals from matrix
attachments and cell–cell interactions.
9 In order to increase
the survivalofstemcell grafts,sometransgenic strategies(for
instance, by engineering stem cells to express AKT, a serine
threonine kinase and a powerful survival signal) have been
pursued.
10 In spite of these endeavors, there is still a need to
develop strategies to enhance differentiation in a controllable
manner and improve the viability of transplanted cells. C2C12
is a mouse myoblast cell line, which is capable of myogenic or
osteogenic differentiations.
11 In this work, we investigated the
myogenic differentiation of C2C12 under the effects of
carboxylated multiwalled CNT (MWCNT 1) and studied the
involved molecular mechanisms. The results demonstrated
that MWCNT 1 promoted myogenic differentiation of C2C12
without using any protein or chemical factor. MWCNT 1 also
improved cell survival under the differentiation conditions.
These effects were originated from the binding of MWCNT 1
to bone morphogenetic protein receptor 2 (BMPR2), suppres-
sing the BMP signaling pathway and regulating basic helix-
loop-helix (bHLH) transcription factors involved in differentia-
tion and apoptosis. Based on this mechanistic understanding,
we successfully modulated myogenicdifferentiation of C2C12
to various levels by surface-chemistry modiﬁcations on
MWCNTs.
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MWCNT 1 promotes myogenic differentiation and inhi-
bits apoptosis. The physicochemical characterization of
MWCNT 1 was summarized in Table 1. MWCNT 1 has an
inner diameter of 5–12nm and an outer diameter and
30–50nm. On the basis of the functional group loading
(0.4mmol/g) as determined by the elemental analysis and
measured surface area (500m
2/g), we estimated that the
average density of modiﬁcation is approximately ﬁve func-
tional groups per 10nm
2. At pH 7.0, MWCNT 1 carries
negative charges. Its solubility in water and plasma is much
better compared with the pristine MWCNT. Inductively
coupled plasma mass spectrometry analysis indicated a
negligible amount of metal impurities excluding the possibility
that they may affect cellular function.
12
C2C12 can differentiate into adipocytes, muscle cells or
osteoblasts under different conditions. It has been reported
that C2C12 cells underwent myogenic differentiation after
transventricular injection into the arterial circulation of the
murine heart.
13 MWCNT 1 showed little cytotoxicity at
concentrations up to 100mg/ml (Supplementary Figure S1).
To mimic the differentiation microenviroment of transplanted
cells, C2C12 cells were incubated in the differentiation
medium (DM) to evaluate their myogenic differentiation under
the inﬂuence of MWCNT 1. C2C12 cells when treated with
MWCNT 1 expressed myosin heavy chain (MYH) protein,
formed myotubes and showed a dose-dependent increase in
fusion index compared with DM controls (Figures 1a–c).
These data demonstrated that MWCNT 1 accelerated
the myogenic differentiation under the differentiation
environment.
Differentiation conditions (low serum) deprived mitogens of
cells and caused an increase in apoptotic cells (20–30%).
14
Microscopic observation indicated that the cell death was
signiﬁcantly decreased by MWCNT 1 treatment (Figures 1d
and e). Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) assay showed that MWCNT 1 treatment
decreased the percentage of TUNEL-positive cells from 23 to
about 8% in 48h (Supplementary Figure S2 and Figure 1f).
The activity of apoptotic effector protein caspase 3
15
dropped to nearly control level (1.2-fold compared with that
in growth medium) (Figure 1g). These data showed that
MWCNT 1 promotes myogenic differentiation as well as
inhibits apoptosis of C2C12 under the differentiation conditions.
The myogenic differentiation of C2C12 was coordinated by
a family of proteins containing bHLH structures including
MyoD, myogenin, myf5, mrf4 and E2A proteins such as
HEB, E12 and E47.
16 The inhibitor of DNA-binding/
differentiation (Id) proteins are negative regulators of
myogenic differentiation.
17 The Id proteins form a complex
with myogenic regulatory factors and prohibit their binding to
DNA to activate the expression of muscle-speciﬁc genes.
17
We ﬁrst evaluated whether MWCNT 1 promoted myogenic
differentiation by altering functions of these two families of
proteins or their interactions.
MWCNT 1 positively regulates functions of bHLH
proteins. We ﬁrst analyzed the effects of MWCNT 1 on
myogenic regulatory factors and Id proteins. Because
of the functional redundancy of MyoD with mrf4
18 and
myogenin with myf5,
19 we analyzed the protein levels
of two myogenic regulatory factors MyoD and myogenin
and one E2A protein HEB. The expression level of MyoD and
HEB did not change, whereas the expression of myogenin
increased (Figure 2a). In the normal medium, MWCNT 1
treatment decreased the expression of all the three Id genes
on both mRNA and protein levels (Supplementary Figure
S3a and Figure 2b). Under the differentiation conditions,
MWCNT 1 treatment also downregulated Id1 and Id3 at the
mRNA level (Supplementary Figure S3b). MyoD is known as
a marker for myogenic commitment and its major function is
to induce the expression of myogenin and cell-cycle
inhibitors such as p21.
16,20 MyoD forms a complex with
E2A protein and activates the expression of target genes by
binding to E-box motifs in the promoter region of these
genes.
16 However, because of their higher afﬁnity to E2A
proteins, Id proteins compromise the MyoD–E2A complex
formation and block the gene expression by binding to E2A
proteins.
17 The nanotube-induced increase in myogenin
expression and decrease in Id proteins expression sug-
gested that MWCNT 1 might abrogate the formation of HEB–
Id complex, thus favoring the formation of HEB–MyoD
complex. Co-immunoprecipitation with HEB followed by
probing the co-precipitated proteins with anti-Id1 and anti-
MyoD antibodies conﬁrmed that Id1 downregulation actually
promoted the HEB–MyoD complex formation (Figure 2c). In
order to further validate that the enhanced myogenin-
expression level after MWCNT 1 treatment is indeed caused
by the elevated HEB–MyoD complex formation, chromatin
immunoprecipitation (ChIP) assay with anti-HEB and anti-
MyoD antibodies was carried out. The results indicated that
MWCNT 1 treatment recruited more HEB–MyoD complex to
the E-box region of the myogenin promoter (Figure 2d). As a
consequence of the increased DNA binding by HEB–MyoD
complex, the activity of the myogenin promoter was
increased by six-folds (Figure 2e).
Myogenin triggers the expression of muscle-speciﬁc
genes by replacing MyoD and forming a dimer with HEB
after the initiation of differentiation (24–48h under the
Table 1 Characterization of MWCNT-COOH
Chemical structure
Suspension in plasma
(after 120h)
Diameter (nm) 30–50 (outer); 5–12 (inner)
Length (mm) 0.5–2.0
Zeta potential (mV in H2O)  42.5
Zeta potential (mV in plasma)  9.3
Functional group loading (mmol/g) 0.4
Fe, Al, Cr and Mn (%) by ICP-MS 0.3, 0.02, 0.002 and 0.00001
Other 19 metals (%) by ICP-MS o0.00008
Binding of carbon nanotube to BMP receptor 2
Y Zhang et al
2
Cell Death and Diseasedifferentiation conditions).
20 A signiﬁcant increase in HEB–
myogenin complex formation after MWCNT 1 treatment was
observed (Figure 2c). A subsequent event is the nuclear
translocation of myogenin to activate the expression of
muscle-speciﬁc genes. Immunocytochemistry showed that
MWCNT 1 accelerated both the expression and nuclear
translocation of myogenin (Figures 2f and g). Together,
these data showed that by negative regulation of Id
proteins, MWCNT 1-enhanced positive regulation of cell-
differentiation machinery.
p21
Cip1/waf-mediated apoptosis inhibition. We were also
interested in investigating how MWCNT 1 suppressed cell
apoptosis. Cdk inhibitors, such as p21
Cip1/waf (hereinafter
p21), can protect cells from apoptosis,
14,21 and p21 expres-
sion was controlled by the bHLH proteins.
22,23 We found that
MWCNT 1 treatment upregulated the p21 promoter activity
(Supplementary Figure S4a) and recruited more HEB–MyoD
complex to bind to p21 promoter (Supplementary Figure
S4b). Western blot analysis showed an increased expression
of p21 from 24 to 72h after MWCNT 1 treatment (Figure 3a).
On the basis of these results and the previous reports,
14,21
we hypothesized that the MWCNT 1-induced elevation of
p21 expression accounted for the apoptosis suppression.
p21 inhibits apoptosis only when it is translocated from
nucleus to mitochondrial membrane.
24 To verify the mito-
chondrial localization of p21, we labeled mitochondria with a
mouse-originated anti-Core II antibody and a Cy3-labeled
secondary antibody, and p21 was labeled with rabbit-
originated anti-p21 antibody and a ﬂuorescein isothiocyanate
(FITC)-conjugated secondary antibody. Our results showed
that p21 proteins were mainly localized in mitochondria in
MWCNT 1-treated cells. In the untreated group, p21 proteins
resided in the nucleus (Figure 3b). At the mitochondrial
membranes, p21 forms a complex with procaspase 3 and
inhibits its activation.
25,26 The enhanced p21–procaspase 3
Figure1 MWCNT1promotesC2C12differentiationandinhibitsapoptosis.(a)Time-dependentMYHproteinexpressionassayedbywesternblotwithanti-MYHantibody.
(b)MyotubeformationinC2C12cellscultured inDMor MWCNT 1(25mg/ml)forvarioustimepoints. Immunocytochemistrywas performedwith anti-MYHantibodyandFITC-
conjugated secondary antibody (scale bar: 200mm). (c) Quantitative analysis of time-dependent cell differentiation under MWCNT 1 concentrations of 25 and 100mg/ml
assayed by nuclear fusion index (*Po0.05). (d and e) Phase-contrast photomicroscopy revealed cell apoptosis after 48h in DM and MWCNT 1 concentration of 25mg/ml.
(f) Quantitative analysis of BrdU-positive nuclei. The percentage of BrdU-positive nuclei in 0h was also shown. (g) Quantitative analysis of caspase 3 activity. Caspase 3
activity in GM group was normalized to 1.0 (*Po0.05). GM, growth medium
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Cell Death and Diseasecomplex formation was observed in a co-immunoprecipita-
tion assay (Figure 3c). MWCNT 1 also inhibited caspase 3
activity (Figure 2f). Therefore, our ﬁndings suggested that
upregulation of the expression of p21 proteins was at least
one mechanism to protect cells from apoptosis under the
differentiation conditions.
The above data demonstrated that MWCNT 1’s down-
regulation of Id protein levels has a critical role in
promoting myogenic differentiation and inhibiting apoptosis
of C2C12. The Id proteins are the targets of the BMP
signaling pathway.
27 We have reported that CNTs inhibit
the BMP signaling pathway
28 and this was conﬁrmed by
Figure 2 MWCNT 1 positively regulates functions of MyoD and myogenin by inhibiting expression of Id proteins. (a) Effects of MWCNT 1 on the expression of MyoD,
myogeninandHEBanalyzedbywesternblots.(b)MWCNT1decreasedtheexpressionofIdproteins.(c)MWCNT1causedadecreaseinHEB–Idcomplexformationandan
increase in HEB–MyoD and HEB–myogenin. Protein complex formations were analyzed by co-immunoprecipitation with anti-HEB antibody followed by probing the co-
precipitated proteins with different antibodies after MWCNT 1 treatment. (d) MWCNT 1 recruiting HEB–MyoD complexes to E-box motifs in the promoter of myogenin gene
assayed by chromatin immuoprecipitation (ChIP) with anti-HEB and anti-MyoD antibodies. Total DNA before immunoprecipitation was used as input controls and b-actin was
used as a control for speciﬁcity (Supplementary Information for details). (e) Myogenin promoter activity enhanced by MWCNT 1. C2C12 was transfected with constructs
containing ﬁreﬂy luciferase gene driven by myogenin promoter and the luminescence intensity was measured after treatment for 48h. The luminescence intensity in DM was
normalized to 1.0. (f) Myogenin expression and distribution in C2C12 cultured in DM or MWCNT 1 for various times. Myogenin-negative cells were indicated by arrows with
dotted line and cells with nuclear translocation of myogenin were shown with arrow heads. Fusion of myogenin-positive nuclei was indicated by arrows with solid line.
Immumnocytochemistry was performed with anti-myogenin antibody and Cy3-conjugated secondary antibody. (scale bar: 50mm). (g) Quantitative analysis of nuclei
expressing myogenin at different time points (*Po0.05)
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29 Here we found that MWCNT 1
also inhibited Id protein expression by suppressing the
BMP signaling pathway. In order to gain further under-
standing of interplays between MWCNT 1 and the BMP
signaling pathway, we investigated the further details in
this context.
MWCNT 1 perturbs the phosphorylation of BMPR1. BMP
signaling is suppressed when the initial membrane-receptor
activation or any of the following signal transduction steps is
partially blocked.
30 In order to reveal how MWCNT 1 blocked
BMP signaling, we examined the effects of MWCNT 1 on
individual signaling steps.
31 We ﬁrst analyzed the phosphor-
ylation of Smad1/5/8. Western blot indicated that while the
level of Smad1/5/8 was unchanged, MWCNT 1 treatment
decreased their phosphorylation level (Figure 4a), suggest-
ing that Smad1/5/8 phosphorylation or an upstream step
was affected. In cells, Smad1/5/8 was phosphorylated by
activated BMPR1. In order to clarify whether MWCNT 1
affected any step downstream of BMPR1 phosphorylation, a
transgenic cell line C33A-2D2 containing ﬁreﬂy luciferase
reporter driven by Id1 promoter was transiently transfected
with constitutively active forms of the type 1 BMP receptor
ALK2 and ALK3 (BMPR1A) to generate C33A-2D2-ALK 2
and C33A-2D2-ALK 3 cells. These constructs mimic the
phosphorylated BMPR1 and are able to constitutively
phosphorylate Smad1/5/8 and transduce intracellular
signals.
30 Incubation of both the transfected cell lines with
MWCNT 1 at various concentrations for different times
showed no dose-dependent inhibition on Id1 promoter
activity, whereas the speciﬁc Smad1/5/8 inhibitor dorsomor-
phin did (Figures 4c–f). These results suggested that MWCNT
1 did not interfere with any step downstream of BMPR1.
Phosphorylation of BMPR1 by BMPR2 after ligand binding
is the ﬁrst step to trigger the intracellular BMP signaling
cascade.
31 In order to investigate whether MWCNT 1
interferes with the phosphorylation process of BMPR1,
the phosphorylated BMPR1A in whole-cell extract was
determined after co-immunoprecipitation with its antibody.
The data showed that MWCNT 1 strongly suppressed
BMP4-induced phosphorylation of BMPR1A (Figure 4b),
suggesting that MWCNT 1 inhibited BMPR1 phosphorylation
by BMPR2.
MWCNT 1 binds to BMPR2 and suppresses BMP
signaling process. The suppression of BMPR1 phosphor-
ylation by MWCNT 1 suggested that its target might be
membrane-bound BMP receptors. Under the transmission
electron microscope (TEM), MWCNT 1 bound to cell surface
or was endocytosed into cells with continued membrane
interactions (Figures 5a and b). We ﬁrst investigated the
spatial proximity of MWCNT 1 with BMPRs. To do this, we
conjugated mouse IgG to MWCNT 1. By an in situ proximity
ligation assay (PLA)
32 using rabbit antibodies to BMPR1A
Figure 3 Induced p21 protects cells from apoptosis. (a) Time-dependent p21 expression analyzed by western blot. The protein expression level was quantiﬁed by the
banddensityusingImageJmethodandtheratio betweenp21 andGAPDHbandswas plottedafter normalizing thatin 0-h groupas 1.0.(b)MWCNT 1-inducedmitochondrial
translocationofp21aftertreatmentfor48h.p21proteinsonlylocatedinthenucleiinDMgroup,whereastranslocatedtomitochondriaafterMWCNT1treatment.Mitochondria
andp21weredetectedsimultaneouslybymouse-originatedanti-CoreIIandrabbit-originatedanti-p21antibodies.Cy3-andFITC-conjugatedsecondaryantibodieswereused.
Scale bar, 5mm. (c) Complex formation between p21 and procaspase 3. Cell extracts after MWCNT 1 treatment for 24h were co-immunoprecipitated with anti-p21 antibody
followed by probing with anti-p21 and anti-procaspase 3 antibodies
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Cell Death and Diseaseand BMPR2, we detected a close proximity between
MWCNT 1 and BMPR2 (10.6 PLA signals per nuclear,
compared with 20.5 PLA signals per nuclear in positive
control of BMPR1A/BMPR2 and 1.8 PLA signals per nuclear
in negative control of bovine serum albumin (BSA)-conju-
gated MWCNT 1 (Supplementary Figures S5a and b)) other
than with BMPR1A (4.0 PLA signals per nuclear) (Figures 5c
and d). This was likely due to a direct binding between
MWCNT 1 and BMPR2. In order to substantiate MWCNT 1/
BMPR2 binding, we also determined ﬂuorescence resonance
energy transfer (FRET) between ﬂuorescent-labeled
MWCNT 1 and BMPR2. MWCNT 1 was labeled with FITC-
conjugated BSA (FITC-BSA) and BMPR2 was labeled with
tetramethyl rhodamine isothiocyanate (TRITC)-conjugated
secondary antibody. FRET acceptor bleaching method
33
measures the donor ‘de-quenching’ in the presence of
acceptor by comparing donor ﬂuorescence intensity before
and after destroying the acceptor by photobleaching. If FRET
is initially present, a resultant increase in donor ﬂuorescence
will occur on photobleaching of the acceptor. We found that
photobleaching TRITC resulted in an increase in the FITC
intensity with an efﬁciency of 15B20% (Figures 5i–n). This
increased efﬁciency is comparable to that reported in
interaction between two ﬂuorescent proteins;
34 hence this
result conﬁrmed the binding between MWCNT 1 and
BMPR2. This binding event abrogated the BMPR1A–
BMPR2 heterodimer formation as shown also by PLA
using antibodies to BMPR1A and BMPR2 after BMP4
Figure 4 MWCNT 1 inhibits BMP signaling by blocking phosphorylation of BMPR1A. (a) Inhibition on BMP signaling by MWCNT 1 shown by decreasing phosphorylation
of Smad1/5/8. (b) MWCNT 1 decreased phosphorylation level of BMPR1A. Whole-cell extract (200mg) from C2C12 cells treated with MWCNT 1 and/or BMP4 (25ng/ml) for
6h was co-immunoprecipitated with anti-BMPR1A antibody followed by probing with anti-phosphorylated-Serine (p-Ser) and anti-BMPR1A antibodies. The level of BMPR1A
in whole-cell lysate was also probed. (c–f) MWCNT 1 did not affect Id1 promoter activity induced by constitutively active BMP receptors. Amino-acid mutations in wild-type
BMP1receptorsALK2andALK3/BMPR1Aproducedligand-independentactivationofBMPsignalinginC33A-2D2-ALK2andC33A-2D2-ALK3cells,whichalsocontainﬁreﬂy
luciferase genes driven by Id1 promoter. The Id1 activity in empty vector-transfected cells was normalized as 1.0. Dorsomorphin (25mM), a speciﬁc inhibitor of the Smad-
dependent BMP signaling pathway was used as positive control
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Cell Death and Diseasetreatment (Figures 5f–h). The interruption of the formation
of BMPR1A–BMPR2 heterodimer markedly suppressed the
BMP4-induced phosphorylation of BMPR1A as analyzed
by immunoprecipitation (Figure 4b). We also found that
MWCNT 1 in culture system neither adsorbed BMP4
ligand (Figure 5e) nor affected their binding to BMPRs
(Supplementary Figures S5c–f). These data demon-
strated that MWCNT 1 affected the BMP signaling
pathway by binding to BMPR2 and compromising its
signaling function.
Our ﬁnding can be summarized into a working model
(Figure 6). By binding to BMPR2 and inhibiting the phosphor-
ylation of BMPR1, MWCNT 1 downregulates the phosphor-
ylation of Smad1/5/8 and reduces the expression of Id
proteins. The decrease in Id proteins expression enhances
the formation of HEB–MyoD complex, which in turn promotes
the expression of myogenin and p21. Myogenin forms
complex with HEB to activate the differentiation-speciﬁc
genes (e.g., MYH) and leads to myogenesis. p21 proteins
translocate to mitochondria to bind and inhibit the activation of
procaspase 3, thereby suppressing apoptosis.
Fine tuning of cell differentiation by surface modiﬁca-
tions on MWCNT 1. Biological perturbations by nanoparti-
cles can be attributed to their size, shape, structure and
surface properties.
35 When the size, shape and structure of
nanoparticles are kept the same, their surface chemistry will
dictate the surface properties such as hydrophobicity,
stereochemistry and charges. The altered surface properties
of CNTs determine their interactions with proteins and other
biological molecules.
36 We hypothesized that the interactions
of CNTs with BMPRs might be modulated by their surface
chemistry. We therefore examined a diverse array of surface-
modiﬁed MWCNTs, which contains 84 members (MWCNT
1–84)
37 for their effects on the activation of BMPRs as
indicated by Id1 promoter activity in C33A-2D2 cells.
MWCNTs with diverse surface-chemistry modiﬁcations gen-
erated various Id1 promoter activations (Supplementary
Figure S6 and Figure 7b). To explore whether we could tune
cell differentiation by modulating BMP signaling activation,
we further investigated MWCNTs 6, 7, 11, 12, 20 and 43
(Figure 7a) for their effects on cell signaling and differentia-
tion. First, we found that they enter cells in a similar manner
Figure 5 MWCNT 1 blocks phosphorylation of BMPR1A by binding to BMPR2. (a and b) TEM images show MWCNT 1s (arrows) bound to cell membranes or in
endosomes. C2C12 cells were incubated with MWCNT 1 (25mg/ml) for 2h before ﬁxation. Scale bar, 100nm. (c–h) MWCNT 1 has a close proximity with BMPR2 and
interferes with BMPR1A–BMPR2 complex formation assayed by in situ PLA. In (c-e) MWCNT 1 was conjugated with mouse IgG, and protein pairs between IgG with rabbit
BMPR2(c),BMPR1A(d) andBMP4(e)antibodiesweredetermined.PLAsignalswereshown inred, andnucleiwerestainedblueby DAPI.(f–h) BMPR1A–BMPR2complex
formation was assayed by in situ PLA after addition of BMP4 (f), BMP4 with MWCNT 1 (g) and BMP4 with noggin (h). C2C12 cells were treated with MWCNT 1 (25mg/ml) or
noggin(200ng/ml) for 2h followedbyBMP4(25ng/ml)treatment for 1h before ﬁxation.Scalebars,50mm. (i–n) MWCNT1 (labeled byFITC)closely associateswith BMPR2
(labeled by TRITC) as detected by FRET. A region in the red rectangle was photobleached at 543nm (TRITC channel) for 50 exposures and images were taken in FITC
(488nm) and TRITC (543nm) channels before and after bleaching. Scale bars, 50mm
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Cell Death and Diseaseas MWCNT 1 as shown by TEM (Supplementary Figure
S7a). Similar to MWCNT 1, they did not inhibit caALK-
induced Id1 activation in C33A-2D2-ALK2 or C33A-2D2-
ALK3 cells (Supplementary Figure S7b). These MWCNTs
also showed various inhibitions on BMPR1A phosphorylation
(Figure 7e). Furthermore, they downregulated phosphoryla-
tion of Smad1/5/8 and the expression of Id proteins in the
same order (Figure 7e). These data strongly showed that
surface-chemistry modiﬁcations conferred different modula-
tions on BMPR and caused different levels of suppression on
the BMP signaling pathway. Therefore, this approach is
promising for ﬁne tuning of cell differentiation through
modulating BMP signaling to a desired level. To test this
possibility, we analyzed the differentiation proﬁle of C2C12
cells into myotubes. Our data showed that the differen-
tiation of C2C12 was regulated to various levels as
shown by the inversely correlated myogenin promoter
activity (Figure 7c) and different expression levels of both
myogenin and the differentiation-marker MYH proteins
(Figure 7e). Expression of the apoptosis-inhibitor p21 was
also regulated (Figure 7e). As a quantitative measure for
terminal differentiation, myotube formation and the nuclear
fusion index were also modulated to various controllable
levels (Figures 7f and d).
Discussion
Rapid and controllable induction of differentiation and
decreasing cell apoptosis are both desired attributes
of medicinal agents in regenerative medicine. These
two aims have been sought out by various strategies
10,38
without much success.
39 Nanomaterials hold enormous
promises in this aspect because they exhibit suitable
physical characteristics and they are able to mimic surface
properties of natural tissues.
40 Therefore, the molecular
understanding of the effects of nanoparticle on stem cell
differentiation is critical to fully develop their application
potential.
In a previous study,
41 incubation of CNT with cell lysate
enhanced protein binding and MS analysis revealed that CNT
bound to murine scavenger receptor macrophage receptor
with collagenous structure in addition to other proteins.
Figure6 AschematicdiagramshowingthemolecularinteractionsinvolvedinMWCNT1-enhancedcelldifferentiationandinhibitionofapoptosis.MWCNT1bindstoBMP
receptor 2 (BMPR2) and inhibits the heterodimer formation between BMPR1 and BMPR2, blocking the phosphorylation of BMPR1. This consequently attenuates the
expression of Id proteins, which are members of the negative HLH family of proteins. Lower Id protein levels reduced their ability to inhibit complex formation between
ubiquitous E-protein (HEB) and tissue-speciﬁc E-proteins (MyoD and myogenin). These positive HLH protein complexes activate the expression of differentiation-speciﬁc
genes (myogenin and MYH) and p21 by binding to E-box motif in their promoter region. p21 translocated from nuclear to mitochondria, where it binds to procaspase 3 and
inhibits cell apoptosis
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Cell Death and DiseaseOur study provides the evidence that nanoparticles bound to
cell-membrane receptors in live cells. Discoveries from this
work in combination with previous reports demonstrate how
CNTs alter cell functions such as differentiation and apoptosis
(Figure 6). The binding of CNTs to BMPR2 weaken the
interactions between BMPR2 and BMPR1 and inhibited
BMPR1 activation. Such weakening is propagated through
the BMP signaling pathway as shown by a downregulation of
Smad phosphorylation, Smad nucleus translocation and Id
protein expression. Reduced Id expression in cell nucleus
changes the regulation of HLH transcription factors and
upregulated cell-differentiation genes and p21, which sup-
presses cell apoptosis. The combined effect is the enhanced
cell myogenic differentiation.
The driving forces for CNTs/protein binding are likely
electrostatic, hydrophobic and p–p stacking interactions.
42
Such interactions are probably not speciﬁc. In fact, CNTs
perturbed cell genome by up- and downregulation of more
than 400 genes and the BMP pathway is only one of the top
ten most-affected signaling pathways.
28 However, one
signiﬁcant ﬁnding from this work is the identiﬁcation that
perturbations onthe BMPsignaling pathway are resulted from
interactions of CNT with BMPR2. On the basis of this ﬁnding,
chemical modiﬁcations on CNTs to alternate its interactions
with BMPR2 become possible. By carrying out chemical
modiﬁcations on CNT surface, we successfully modulated
myogenic differentiation of C2C12 to various levels by
controlling CNT–BMPR2 interactions. Chemical basis for
Figure 7 Surface-modiﬁed MWCNTs’ ﬁne-tune cell differentiation. (a) Chemical structures of CNTs with differently modiﬁed surfaces. (b and c) Variable activation of
MWCNTs(25mg/ml)onId1promoter(b)andmyogeninpromoter(c)aftertreatmentfor24and48h,respectively.(d)EffectsofMWCNTson terminalmyogenicdifferentiation
of C2C12 evaluated by nuclear fusion index. MWCNTs with more intense inhibition of Id1 promoter showed higher capability to promote nuclear fusion. (e) Western blot of
proteins involved in BMP signaling, cell differentiation and anti-apoptosis. For phosphorylated BMPR1A, whole-cell extracts (200mg) from C2C12 cells treated with MWCNTs
(25mg/ml) and BMP4 (25ng/ml) were immunoprecipitated with BMPR1A antibody followed by immunoblotting with an antibody to p-Ser. The level of BMPR1A in C2C12
whole-cell extracts was also probed. For phosphorylated Smad1/5/8, Smad1 and Id1 protein assays, BMP4 (25ng/ml) was added to DM simultaneously with MWCNTs
to stimulate BMP signaling. The treatment time is also indicated. (f) Representative images showing differential myotube formation after treatment with MWCNTs (25mg/ml)
for 72h. Immunocytochemistry was performed using MYH antibody and FITC-conjugated secondary antibody (scale bar: 100mm)
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Cell Death and Diseasesuch regulation was explored by analyzing the relationships
between various structural parameters of CNTs’ surface
molecules and the Id1 promoter activities. Preliminary studies
showed that molecular surface areas and polar surface areas
exhibited some correlations with the effects of CNTs on BMP
signaling. However, the correlation was not very tight,
suggestingthatmorecomplexfactorssuchasothermolecular
and CNT interactions were also involved in the regulation of
cell differentiation.
Althoughthebiologicalimpactsofnanomaterials aremostly
unknown, and some effects are found to be harmful, this
work points out that beneﬁcial effects can be initiated by
CNTs. This investigation characterized in molecular terms
how CNTs promote cell myogenic differentiation by binding to
BMPR2 and suppress BMP signaling. Furthermore, we
successfully modulated effects of CNTs on differentiation,
modifying surface chemistry on CNTs. By this result, we
demonstrate the human control of the biological impacts of
nanomaterials and open an avenue for the applications of
nanomaterials in regenerative medicine.
Materials and Methods
Materials, cell lines, reagents and antibodies. MWCNT 1 and the
combinatorial array of surface-modiﬁed MWCNTs were prepared as reported.
37
Stock solutions of MWCNTs (1mg/ml) in ddH2O was prepared and sterilized at
1211C for 30min and sonicated before use.
C2C12 cells o20 generations were grown in growth medium (Dulbecco’s
minimum essential medium (DMEM) medium supplemented with 20% fetal bovine
serum) and were placed in DM (DMEM medium supplemented with 2% horse
serum) when culture reached 80% of conﬂuence (t¼0h). C33A-2D2 was
constructed using human cervical carcinoma cell line C33A. Single-cell clones from
C33A that responded to human recombinant BMP4 were selected after they were
transfectedwithamultimerizedBMP-responsiveelement(BRE)fromthemouseId1
promoter linked to the ﬁreﬂy luciferase gene (pGL4-BRE-Luc). The EC50 value for
BMP4-induced speciﬁc BRE-mediated activity was 1ng/ml. The control C33A line
expressing the pGL4-luciferase vector only (C33A-empty vector) was also
constructed as a control for all the assays.
ConstitutiveactiveALK2andALK3constructsweregiftsfromPaulBYu,Harvard
Medical School. Myogenin-luciferase and p21-luciferase constructs were gifts from
Michael A Rudnicki, Ottawa Health Research Institute, and Carme Gallego,
Universitat de Lleida.
Lipofectamine 2000 Transfection Reagent, Opti-MEM I Reduced-Serum
Medium, and RIPA Buffer (10 , no. 9806) were purchased, respectively, from
Invitrogen (Grand Island, NY, USA) and Cell Signaling (Danvers, MA, USA). The
luciferase assay system (E1500) and the ChIP assay kit (no. 17–295) were
purchased, respectively, from Promega (Madison, WI, USA) and Millipore (Billerica,
MA, USA). Caspase3/CPP32 Colorimetric Assay Kit (k106–100) was purchased
from BioVision (Milpitas, CA, USA).
Goat anti-mouse and goat anti-rabbit secondary antibodies (no. 926–32220 and
926–32221) used for western blot analysis are products of LI-COR Biosciences
(Lincoln, NE, USA). All the ﬂuorescent-labeled secondary antibodies used for
immunocytochemistry were commercial, obtained from Jackson ImmunoResearch
(West Grove, PA, USA). Primary antibodies used in in situ PLA including rabbit
antibodies to BMP4 (N-term AP1715a), BMPR1A (C-term, AP2004b) and BMPR2
(N-term, AP2006a) were purchased from Abgent (San Diego, CA, USA). Mouse
antibody to BMPR2 (CP 10368) and BMP4 (PA003869-CB12470) were purchased,
respectively, from Cell Application Inc. (San Diego, CA, USA), BD Pharmingen
(San Jose, CA, USA), and Syd Labs (Boston, MA, USA). MyoD (554130)
and myogenin (556358) were commercial, obtained from BD Pharmingen.
HEB (A-20), MYH (H-300), p21 (H-164), BMPR-IA (H-60), caspase 3 (3CSP03)
and phosphorylated-serine (16B4) antibodies, Protein A/G PLUS-Agarose
Immunoprecipitation Reagent (sc-2003), normal mouse IgG (sc-2025) and normal
rabbit IgG (sc-2027) are products of Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA, USA). Antibodies to phospho-Smad1 (Ser463/465)/Smad5 (Ser463/465)/
Smad8 (Ser426/428) (no. 9511) was from Cell Signaling. Smad1/5/8/9 antibody
(ab72504) was from Abcam (Cambridge, MA, USA). Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH; G9545) antibody was purchased from Sigma-Aldrich
(St. Louis, MO, USA). The Id1 (BCH-1/37-2-50), Id2 (BCH-3/9-2-8-50) and Id3
(BCH-4/6-1-50) antibodieswerefrom BioCheck(Foster City, CA, USA). ComplexIII
subunit Core 2 monoclonal antibody (MS304-SP) was commercial, obtained from
MitoSciences (Eugene, OR, USA).
Immunocytochemistry. For immunocytochemistry assays, cells were
seeded on 22 22-mm
2 cover slips (Corning Life Sciences, Tewksbury, MA,
USA) and treated with poly-D-lysine. After ﬁxing with cold 4% paraformaldehyde
in PBS for 15min and membrane permeabilization with 0.25% Triton X-100 for
10min, cells were blocked with 1% BSA in PBS containing 0.5% Tween-20 for
30min followed by 1h incubation with primary antibodies and 1h incubation
with FITC- or cy3-conjugated secondary antibodies at room temperature. Cells
were rinsed and mounted on cover slips with mounting medium containing
40,6-diamidino-2-phenylindole (DAPI; Vector Lab, Burlingame, CA, USA).
Fluorescence images were taken using a Zeiss (Peabody, MA, USA) LSM 510
confocal microscope with a  40 objective lens.
Calculation of nuclear fusion index. The nuclear fusion index was
calculated by the number of nuclei in cells containing two or more nuclei/total
nuclei  100%. For each experiment, 300–500 nuclei were counted.
Primers for PCR. Id1, forward: 50-CGCTGCAGGCCCTAGCTGTT-30, reverse:
50-TGGAACACATGCCGCCTCGG-30 (391bp); Id2, forward: 50- GCAGATCGCC
CTGGACTCGC-30, reverse: 50-GGCCGGAGAACGACACCTGG-30 (376bp); Id3,
forward: 50-CTACGAGGCGGTGTGCTGCC-30,r e v e r s e :5 0-CTGCGTTCGGGAGG
TGCCAG-30 (329bp); and b-actin, forward: 50-AAATCGTGCGTGACATCAAA-30,
reverse: 50-AGAAGGAAGGCTGGAAAAGA-30 (180bp). Primers for ChIP assay,
p21, forward: 50-ACAGTTGGTCAGGGACAGACCCA-30,r e v e r s e :5 0-TCTCGGCT
GCTGCAGTTGG-30 (305bp); myogenin, forward: 50-GAATCACATGTAATCCAC
TGGA-30,r e v e r s e :5 0-ACACCAACTGCTGGGTGCCA-30 (180bp) (E-box motif
sequences highlighted by red); and b-actin, forward: 50-AAATCGTGCGTGACATC
AAA-30,r e v e r s e :5 0-AGAAGGAAGGCTGGAAAAGA-30 (180bp).
Semi-quantitative reverse transcription PCR (RT-PCR) and
quantitative RT-PCR (qRT-PCR). RNA was extracted with an RNeasy
Mini Kit and cDNA was synthesized with SuperScript III ﬁrst-strand synthesis
system for RT-PCR (both kits are commercial, obtained from Invitrogen). For semi
qRT-PCR, 1.5ml of cDNA and 5ml of primers (10mM) were used for one reaction.
A total of 20 cycles were run with a C1000 thermal cycler (Bio-Rad, Hercules,
CA, USA) and each cycle consisting of denaturation at 941C for 30s, annealing at
621C for 30s and extension at 721C for 1min. qRT-PCR was run in a 7900HT
fast real-time PCR system with the following cycling conditions: enzyme activation
at 951C for 20s; 40 cycles for denaturing at 951C for 1s; and anneal/extend at
601C for 20s. Finally, 0.25ml of cDNA and 0.2ml of primers (10mM) in one 10-ml
reaction were used with Fast SYBR Green Master Mix (Applied Biosystems,
Carlsbad, CA, USA). Every reaction was run in triplicate in a 384-well clear optical
reaction plate. All the instruments and reagents used for real-time PCR were from
Applied Biosystems.
TUNEL assay. TUNEL assays were conducted with an ApopTag Plus
Fluorescein In Situ Apoptosis Detection Kit (S7111; EMD Millipore, Billerica,
MA, USA) following the indicated protocol. Brieﬂy, cells were treated as
indicated, ﬁxed in 1% paraformaldehyde, washed in PBS three times, incubated
in equilibration buffer for 10min and incubated with terminal deoxynucleotidyl
transferase for 60min at 371C. Cells were washed with stop buffer for 10min and
then incubated with anti-digoxigenin conjugate for 30min at 251C. After washing in
PBS, cells were mounted with DAPI and viewed and photographed on a microscope
with a ﬂuorescent attachment.
Caspase 3 activity assay. After being exposed to DM with or without CNTs
for 24h, cell lysates were prepared and 200mg of proteins were used for caspase
3 activity assays. Samples were read at 400nm in a microtiter plate reader and
fold increase in caspase 3 activity was determined by comparing with the level in
cells cultured in growth medium.
Co-immunoprecipitation. Cell lysates were extracted with 1  RIPA Buffer,
and 200mg of lysate was used for each immunoprecipitation. Before precipitation
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normal mouse or rabbit IgG (corresponding to the host species of the primary
antibody) together with 20ml of resuspended Protein A/G Plus-Agarose. Each
precipitation used 1mg of primary antibodies and 20ml of Protein A/G plus-agarose.
After centrifugation, samples were boiled in 1% SDS solution and analyzed by
western blot. All western blots were imaged with an Odyssey Infrared Imaging
System (LI-COR Biosciences).
ChIP assay. ChIP is a method to determine the identity and quantity of DNAs
that bind particular proteins of interest. Following the breakage of DNA molecules
into pieces by sonication, the protein–DNA complex can be immunoprecipitated
out from the cellular lysate by using an antibody that is speciﬁc to a putative DNA-
binding protein. Then the identity and quantity of DNA bound by the protein can
be analyzed using PCR. After optimization of DNA-shearing conditions, the
manufacturer’s standard protocol for ChIP was followed. About 1 10
6 C2C12
cells in a 10-cm dish were treated with 1% formaldehyde for 10min at 371C. Cells
were washed twice with cold PBS containing protease inhibitors and suspended in
200ml SDS lysis buffer in a 1.5ml eppendorf tube, which was then held in ice
water. Sonication was applied to the cell pellets for a total of 18min using a 130-W
ultrasonic processor (model: VCX 130) accessorized with a 6-mm probe (model:
CV18) (VWR International Ltd, Hunter Boulevard, England) with the following
setting: amplitude setting 15% using 15s pulses with 30s cool-down intervals
between pulses. About 20ml of sonicated cell supernatant was kept as input samples
and the rest was diluted by 10-fold. After immunoprecipitation with anti-HEB and anti-
MyoD antibodies, 60ml of protein A agarose/salmon sperm DNA was added for 1h of
culture, followed by centrifuge. The complex was eluted and histone–DNA crosslinks
were reversed by heating at 651C for 4h. DNA was recovered by phenol/chloroform
extraction. Finally, 5ml of DNA suspension was used for PCR cycling.
In situ PLA. Cells were seeded on 35-mm glass-bottom dishes (MatTek
Corp., Ashland, MA, USA). After treatment, cells were ﬁxed with cold 4%
paraformaldehyde for 15min at room temperature followed by cell-membrane
permeabilization with 0.25% Triton-X-100 in PBS for 10min. The cells were
washed three times with PBS, blocked for 1h at room temperature with 1% BSA in
PBS containing 0.1% Tween-20 and incubated with the indicated antibody pairs in
a cell incubator at 371C. Duolink in situ PLA (Olink Bioscience, Uppsala, Sweden)
was performed according to the manufacturer’s instructions. Images were taken
using an Olympus Research Inverted System Microscope (Olympus, Center
Valley, PA, USA) with IX81 LUCplan FLN objectives and cellSen Dimension
software (1.4.1; Olympus). The paired primary antibodies used included rabbit and
mouse BMP4 antibody, rabbit BMPR1A antibody and rabbit and mouse BMPR2
antibody. For preparation of IgG-conjugated MWCNT 1, mouse IgG (100mg,
Santa Cruz Biotechnology, Inc.) or BSA (100mg) was mixed with MWCNT 1 (50ml
of the supernatant of 0.5mg/ml aqueous solution after being centrifuged at
10000 g for 1min) in water (ﬁnal volume, 400ml) and shaken overnight at 41C.
The mixture was centrifuged at 16000 g for 30min and the pellet was
resuspended in 100ml of water. Finally, 50mg/ml-conjugated MWCNT 1 was used
for cell treatment (2h).
FRET. FRET was performed using a Zeiss LSM 510 Meta microscope with a
 63 oil objective lens, all controlled by Zen 2009 software (Peabody, MA, USA). For
labeling MWCNT 1, 200ml of the supernatant of aqueous MWCNT 1 suspension
(0.5mg/ml, centrifuged at 10000 g for 1min) was mixed with 4.2mg of FITC-
BSA (Sigma, St. Louis, MO, USA) in 0.6ml of ddH2O and shaken overnight at
41C. The mixture was centrifuged at 16000 g for 30min to pellet MWCNT 1,
and the pellet was washed once with PBS. Finally, the pellet was suspended in
0.2ml of ddH2O. C2C12 cells were seeded on 35-mm glass-bottom dishes
(MatTek Corp.). After incubation with FITC-conjugated MWCNT 1 (50mg/ml) for
2h, cells were washed with PBS twice to remove free MWCNT 1. Samples were
prepared as for immunocytochemistry. FRET was detected by an acceptor
photobleaching method. This method involves measuring the donor de-quenching
in the presence of an acceptor. This can be done by comparing donor
ﬂuorescence intensity in the same sample before and after destroying the acceptor
by photobleaching. If FRET was initially present, a resultant increase in donor
ﬂuorescence will occur after photobleaching of the acceptor. A selected region of
interest was irradiated with the 543-nm laser line (70% bleach power, 50 iterations)
for 12s to photobleach TRITC. FITC and TRITC images were collected immediately
after photobleaching, and FRET was measured as an increase in FITC ﬂuores-
cence intensity. The FRET efﬁciency was calculated as FRETeff¼1–Dpre/Dpos
using the Zen 2009 software, taking into account background noise in each
channel, where Dpre and Dpos are, respectively, the even FITC ﬂuorescence
intensity in the selected region before and after photobleaching.
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Cell transfection and luciferase activity assay. C2C12 or C33A-2D2
cells were seeded in 24-well plates. After overnight culture, the cell conﬂuence
reached about 80–90%. Next, 0.6mg of plasmids mixed with Lipofectamine 2000
at a ratio 1:3 (w/v) in 100ml of Opti-MEM I Reduced-Serum Medium was used for
transfecting cells in one well. A pcDNA3.1 empty vector was used as control for
caALK2 and caALK3 constructs and a pGL3 empty vector was used as control
for myogenin-luciferase and p21-luciferase constructs. A pGL3 control vector
containing SV40 promoter and enhancer sequences was used to monitor the
transfection efﬁciency simultaneously. Six hours after transfection, cells were
changed to fresh medium, and 24h after transfection, cells were exposed
to CNTs. After the indicated time, cell lysates were prepared by adding
80mlo f1   RIPA buffer to each well. Protein concentration was detected
with a BCA Protein Assay Kit (Thermo Scientiﬁc, Barrington, IL, USA). A luciferase
activity assay was conducted in a white 384-well plate and detected with an
Envision 2012 Multilabel Reader (PerkinElmer, Waltham, MA, USA). Finally, 4ml
of the lysates and 25ml of Steadylite Plus substrate were used for a one-well
assay. The luciferase activity was normalized as luminescence intensity divided
by the protein concentration of the same lysate sample.
Id1 promoter activity assay. Approximately 20000 C33A-2D2 cells per well
were seeded in white 96-well plates and cultured overnight. Each CNT (100mg/ml)
from the combinatorial array was incubated with cells for 24h before BMP4 (25ng/ml)
was added. After incubation for another 24h, 100ml of Steadylite Plus substrate was
added and luminescence intensity was determined. To normalize luciferase activity,
a cell viability assay with the same CNT exposure was performed with the XTT
method. The luminescence intensity divided by the number of viable cells in each
well was used and the value in medium was set as 1.
Statistical analysis. The two-sided student’s t-test was used to analyze
differences between experiments. Data are reported as mean values±S.D. from
multiple determinations. P-values o0.05 were considered statistically signiﬁcant
and all the statistical calculations were carried out using SigmaPlot 10.0 (Systat
Software, Chicago, IL, USA).
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